USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway
Authors:
- 1 April 2017
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 486 (1) , 184-190
Abstract
No abstract availableKeywords
Funding Information
- Jiangxi Province Natural Sciences Fund (20132BAB215019)
This publication has 28 references indexed in Scilit:
- Ubiquitin-specific protease 39 is overexpressed in human lung cancer and promotes tumor cell proliferation in vitroMolecular and Cellular Biochemistry, 2016
- Knockdown of USP39 induces cell cycle arrest and apoptosis in melanomaTumor Biology, 2016
- Lentivirus-mediated inhibition of USP39 suppresses the growth of gastric cancer cells via PARP activationMolecular Medicine Reports, 2016
- State of the art and future directions of pancreatic ductal adenocarcinoma therapyPharmacology & Therapeutics, 2015
- USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivoOncology Reports, 2015
- Important Role of SUMOylation of Spliceosome Factors in Prostate Cancer CellsJournal of Proteome Research, 2014
- Progress in the knowledge and treatment of advanced pancreatic cancer: From benchside to bedsideCancer Treatment Reviews, 2014
- Deubiquitylases From Genes to OrganismPhysiological Reviews, 2013
- Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of Aurora BCell Cycle, 2008
- Analysis of mortality rates for pancreatic cancer across the worldHPB, 2008